Potential Mesothelioma Drug Wins Orphan Status from the European Commission
Cambridge, Mass.-based Verastem hopes to bring to the table a new treatment option for patients with asbestos-caused cancer
Cambridge, Mass.-based Verastem hopes to bring to the table a new treatment option for patients with asbestos-caused cancer